Black Diamond Therapeutics Inc

NASDAQ:BDTX   3:59:55 PM EDT
1.59
-0.07 (-4.22%)
Earnings Announcements

Black Diamond Therapeutics Says Cash Runway Extended Into Q3 2024

Published: 05/11/2022 22:03 GMT
Black Diamond Therapeutics Inc (BDTX) - Financial Position Strengthened and Cash Runway Extended Into Third Quarter of 2024.
Qtrly Loss per Share $0.70.
Q1 Earnings per Share View $-0.75 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.72

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.74

More details on our Analysts Page.